Among them is one who has already been "prepared with many medicinal products," he said.
Industry officials said about 85 percent of medicinal products sold in Europe would be affected.
The second point is the idea of added therapeutic value for a new medicinal product.
That is not the case with human medicinal products, but negative effects will indeed be taken into account.
The quality requirements to be met are the same as those for all medicinal products.
Patients, nurses and doctors should all have access to the best possible information on a given medicinal product.
We must give all European citizens the same opportunity to access information on medicinal products.
Doctors must continue to be the main source of information on medicinal products.
I think that patients must have access to better information about medicinal products subject to medical prescription.
The debate on the single market in medicinal products will continue.